-
Symbol
-
AUTL on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Latest Disclosed Ownership
-
15.4M shares
-
Security Ownership
-
5.8%
MAK Capital Fund LP ownership in Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL)
2025-06-25 - MAK Capital Fund LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.4M shares of Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL).
This represents 5.8% percent ownership of the company.